News

BIO INX and Puredyne are currently working together on a project to give even greater priority to combining the optimum biomaterial with precise printing technology. Gentle material handling and precise dispensing is the key for gaining the best results. At this year's Termis conference in Manchester, the Puredyne team met the Belgian biomaterial manufacturer in person for the first time.

Five Belgian companies and research centres are joining forces in the AstroCardia project. With that project, they are making it their mission to improve heart health. And they are doing so in a very special place: in space. This is where they are aiming to better study heart ageing and create a suitable research model for the heart.

Biofabrication or 3D bioprinting aims to create tissue constructs for numerous applications. One crucial aspect of the technology is the use of suitable materials to enable the 3D printing of living cells which are called bioinks. the present IraSME research project Human bioinks for 3D printing (HU3DINKS) aims develop human tissue-based bioinks for multiple 3D bioprinting technologies.

Revolutionary BIO INX reinforces Flanders as a world leader in 3D bioprinting and biotechnology

Cooperation of UpNano and BIO INX yields further advancement: Two-stage 3D-printing of organ-on-chip devices with encapsulated live cells is possible.

Ghent, 27/03/2023 - BIO INX, a leading manufacturer of high-resolution materials for bioprinting, announces the launch of its latest product, HYDROTECH INX N200. The revolutionary new resin is the world's first hydrogel resin for Two-Photon Polymerization (2PP) that enables macroscale 3D printing (i.e. up to a few mm’s) by taking advantage of Nanoscribe’s patented Dip-in Laser Lithography (DiLL).

We are thrilled to announce the publication of our latest review on Two-Photon Polymerization (2PP) for biomedical applications, which highlights the potential for high-resolution bioprinting to transform the field of biofabrication.

3D Biofabrication is an emerging application field of high-precision 3D printing. In 3D Biofabrication, cells are utilized as building blocks to precisely construct living materials, such as tissues, for pharmaceutical and regenerative medicine applications. Now, BIO INX and Nanoscribe are launching a new bio resin (HYDROBIO INX N400) enabling printing in the presence of living cells.

Bio INX announced a capital raise of 700 000 euro from a combination of private investment and public funding. BIO INX is a recent start up focusing on the development and commercialization of bio inks, which are materials suitable for the 3D printing of cells and tissues for 3D bioprinting.

The fresh start-up BIO INX BV (Zwijnaarde, Belgium), focusses on the development and commercialization of innovative materials for the 3D printing of cells and tissues. It originates from the XPECT INX project from Ghent University and is now rebranding to BIO INX during incorporation.